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Abstract
Background: Numerous nerve conduction tests are used for the electrodiagnosis of carpal tunnel
syndrome (CTS), with a wide range of sensitivity and specificity reported for each test in clinical
studies. The tests have not been assessed in population-based studies. Such information would be
important when using electrodiagnosis in epidemiologic research. The purpose of this study was to
compare the diagnostic accuracy of various nerve conduction tests in population-based CTS and
determine the properties of the most accurate test.
Methods: In a population-based study a questionnaire was mailed to a random sample of 3,000
persons. Of 2,466 responders, 262 symptomatic (numbness/tingling in the radial fingers) and 125
randomly selected asymptomatic responders underwent clinical and electrophysiologic
examinations. A standardized hand diagram was administered to the symptomatic persons. At the
clinical examination, the examining surgeon identified 94 symptomatic persons as having clinically
certain CTS. Nerve conduction tests were then performed on the symptomatic and the
asymptomatic persons by blinded examiners. Analysis with receiver operating characteristic (ROC)
curves was used to compare the diagnostic accuracy of the nerve conduction tests in distinguishing
the persons with clinically certain CTS from the asymptomatic persons.
Results: No difference was shown in the diagnostic accuracy of median nerve distal motor latency,
digit-wrist sensory latency, wrist-palm sensory conduction velocity, and wrist-palm/forearm
sensory conduction velocity ratio (area under curve, 0.75–0.76). Median-ulnar digit-wrist sensory
latency difference had a significantly higher diagnostic accuracy (area under curve, 0.80). Using the
optimal cutoff value of 0.8 ms for abnormal sensory latency difference shown on the ROC curve
the sensitivity was 70%, specificity 82%, positive predictive value 19% and negative predictive value
98%. Based on the clinical diagnosis among the symptomatic persons, the hand diagram (classified
as classic/probable or possible/unlikely CTS) had high sensitivity but poor specificity.
Conclusions: Using the clinical diagnosis of CTS as the criterion standard, nerve conduction tests
had moderate sensitivity and specificity and a low positive predictive value in population-based CTS.
Measurement of median-ulnar sensory latency difference had the highest diagnostic accuracy. The
performance of nerve conduction tests in population-based CTS does not necessarily apply to their
performance in clinical settings.
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Background
Nerve conduction tests are commonly used in the assess-
ment of patients with numbness, tingling and pain in the
hands. Carpal tunnel syndrome (CTS) is one of the most
common disorders for which nerve conduction tests are
performed. A variety of median nerve motor and sensory
tests have been introduced for the purpose of establishing
the presence of median neuropathy in patients with CTS
[1]. Previous publications involving the electrodiagnosis
of CTS have reported a wide range of results for the sensi-
tivity of median nerve distal motor latency (29% to 81%),
wrist-digit sensory latency (44% to 100%), and wrist-
palm sensory conduction velocity (45% to 100%), and of
median-ulnar sensory latency difference (57% to 100%)
[2]. All these reports involved referred patients; no popu-
lation-based studies have assessed the performance of var-
ious nerve conduction tests in CTS. Such information
would be important if electrodiagnosis is to be used in ep-
idemiologic research.
Practice parameter for electrodiagnosis in CTS has been
published [3] and recently slightly modified [4,5]. The
proposed standards are measurement of median nerve
wrist-digit sensory conduction and, when this is normal,
comparison of median and ulnar nerve sensory or mixed
conduction over a 7 to 8-cm distance across the wrist,
comparison of median with radial or ulnar nerve sensory
conduction across the wrist,or  comparison of median
nerve sensory or mixed conduction in the carpal tunnel
with that in the forearm. Median nerve distal motor laten-
cy was not considered as standard.
A standardized self-administered hand symptom diagram
has been introduced as a diagnostic aid in CTS both in ep-
idemiologic and clinical setting [6,7]. The reliability and
performance of the hand diagram have not previously
been evaluated in population-based studies.
We used nerve conduction tests in a population-based
study of CTS [8]. The main purpose of the present analysis
was to compare the diagnostic accuracy of various tests
and determine the properties of the most accurate test
when used in population-based CTS. A secondary objec-
tive was to evaluate the performance of the standardized
hand symptom diagram.
Methods
A sample of 3,000 persons, aged 25–74 years, was ran-
domly selected from the population register of the
170,000 inhabitants of a southern Swedish region. The
Ethics Committee at Lund University's Medical Faculty
approved the study. A questionnaire inquiring about de-
mographics, general health, medical history, as well as the
presence of numbness, tingling or pain in any part of the
body was mailed to the 3,000 persons. Two reminders
were mailed when necessary. All responders who reported
numbness and/or tingling in the median nerve distribu-
tion in the hands at least twice weekly during the preced-
ing four weeks were invited to undergo clinical
examination and nerve conduction tests. Control persons
randomly selected among the responders who did not re-
port any symptoms in the hands, systemic disease, previ-
ous wrist fracture or previous surgery for CTS were also
invited for examinations.
The symptomatic persons who attended the examination
completed a standardized hand diagram on which they
marked pain, numbness, tingling and loss of sensation
(each symptom was marked on 2 diagrams depicting the
dorsal and volar aspects of the hand and upper extremity);
the diagram classifies CTS into four categories (classic,
probable, possible, or unlikely) [7]. The symptomatic per-
sons were then examined by the same hand surgeon who,
based only on the history and clinical findings, diagnosed
each person as having clinically certain CTS or uncertain
CTS. The diagnosis of clinically certain CTS required the
presence of recurring nighttime or activity-related numb-
ness or tingling involving the palmar aspects of at least
two radial fingers. The presence of positive Tinel or Pha-
len's test and of median nerve sensory or motor deficit was
considered supportive of the diagnosis. All hands on
which surgery for CTS had been performed were excluded.
The control persons were examined to verify the absence
of hand symptoms.
Following the clinical examination the symptomatic and
asymptomatic persons underwent bilateral nerve conduc-
tion tests performed by three blinded technicians using
the Viking IV apparatus (Nicolet, Madison, WI). Hands
with skin temperature below 30°C were warmed. The
nerve conduction tests were done using the Kimura tech-
nique [9] that utilizes anatomical landmarks and includ-
ed measurements of median nerve distal motor latency,
long finger-wrist sensory latency, and sensory conduction
velocity in the forearm, wrist-palm, and palm-digit seg-
ments, as well as ulnar nerve small finger-wrist sensory
latency.
The hand symptom diagrams were rated independently
by two blinded orthopedic surgeons according to the
specified criteria [7]; both surgeons were blinded to the
clinical and electrophysiological data. A random sample
of 63 diagrams was selected and given to each of the two
surgeons for repeated rating.
Statistical analysis
The mean values and 95% confidence intervals for the
neurographic variables were calculated for the right hands
and the values for persons diagnosed with clinically cer-
tain CTS were compared with those for two groupsBMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/9
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(asymptomatic controls only and asymptomatic controls
combined with the symptomatic persons diagnosed with
clinically uncertain CTS). The Mann-Whitney U test was
used to compare these groups. Analysis with receiver op-
erating characteristic (ROC) curves [10,11] was used to
compare the diagnostic power of the nerve conduction
tests performed in discriminating the persons with clini-
cally certain CTS from the asymptomatic controls. An
ROC curve (a graph of "sensitivity" and "1 minus specifi-
city" for different cutoff values) is used to compare the ac-
curacy of diagnostic tests; larger area under curve indicates
higher accuracy [11]. The tests compared were median
nerve distal motor latency, long finger-wrist sensory laten-
cy, and wrist-palm sensory conduction velocity, as well as
median-ulnar sensory latency difference and comparison
of median nerve sensory conduction in the carpal tunnel
with that in the forearm. The area under each test's ROC
curve and the statistical significance of the difference be-
tween the ROC curves were determined using the ROCKIT
software [12]. The ROC analysis comprised all sympto-
matic and control hands. The test shown to have the high-
est diagnostic accuracy was then further analyzed with
regard to sensitivity, specificity and predictive values using
the optimal cutoff value (value that minimizes sum of
false positives and false negatives) as shown on the ROC
curve.
The proportion of diagrams classified as "classic/probable
CTS" by at least one rater and those classified as "possible/
unlikely CTS" by both raters were calculated for the per-
sons diagnosed with clinically certain CTS and for those
with clinically uncertain CTS. Assessment of interrater and
intrarater reliability for the hand diagram was done using
the kappa coefficient.
Results
Survey
Of the 2,466 survey responders, 354 reported numbness
and/or tingling in the median nerve distribution in the
hands.
Clinical examination
Of the 287 (81%) symptomatic responders who attended
the clinical examination, 25 were excluded because of pre-
vious surgery for CTS in the symptomatic hand, absence
of symptoms in the median nerve distribution (10 per-
sons), or unwillingness to undergo nerve conduction
tests. Of the remaining 262 symptomatic persons, 94
(67% women) were diagnosed by the examining surgeon
as having clinically certain CTS. The mean age of these
persons was 52 (SD, 13) years. Symptoms were bilateral
in 59 persons (63%) and right-sided in 27 persons. The
168 persons (65% women) who were diagnosed with
clinically uncertain CTS had a mean age of 53 (SD, 13)
years. Symptoms were bilateral in 104 persons (62%) and
right-sided in 51 persons. Of the 134 asymptomatic re-
sponders who attended the clinical examination, 9 were
excluded (7 had numbness and tingling in the hand) and
the remaining 125 (55% women) underwent nerve con-
duction tests. The mean age of these persons was 51 (SD,
14) years.
Hand diagram
The hand symptom diagram was completed by 92 of the
94 persons diagnosed with clinically certain CTS; 83
(90%) were classified as "classic/probable CTS" (82 by
both raters) and 9 as "possible/unlikely CTS". The dia-
gram was completed by 163 of the 168 persons with clin-
ically uncertain CTS; 105 (64%) were classified as "classic/
probable CTS" (99 by both raters) and 57 (36%) as "pos-
sible/unlikely CTS". Thus, using the clinical diagnosis of
CTS as criterion standard the hand diagram had at best
90% sensitivity and 39% specificity among this popula-
tion-based sample of persons with numbness and tingling
in the hand.
High interrater reliability (kappa, 0.89) and intrarater re-
liability (kappa, 0.92 and 0.96) was found.
Nerve conduction tests
The 86 persons with clinically certain CTS involving the
right hand had significantly worse median nerve latencies
and conduction velocities than the controls, but ulnar la-
tencies were similar (Table 1). Analysis with ROC curves
showed no statistically significant differences between
median nerve distal motor latency, digit-wrist sensory la-
tency, wrist-palm sensory conduction velocity, and wrist-
palm/forearm sensory conduction velocity ratio in the
power to discriminate the persons with clinically certain
CTS from the asymptomatic controls (area under ROC
curve, 0.75–0.76). Median-ulnar digit-wrist sensory laten-
cy difference demonstrated significantly higher diagnostic
accuracy with area under ROC curve of 0.80 (Table 2).
Analyses restricted to women or men or to persons with
"classic/probable CTS" diagrams gave similar results.
Using the optimal cutoff value of 0.8 ms for abnormality,
median-ulnar nerve digit-wrist sensory latency difference
had a sensitivity of 70%, a specificity of 82%, a positive
predictive value of 19% and a negative predictive value of
98% (Table 3).
Discussion
The present study is the first population-based investiga-
tion that compared the performance of various nerve con-
duction tests in the diagnosis of CTS. The results revealed
that measurement of median nerve distal motor latency,
digit-wrist sensory latency, and wrist-palm sensory con-
duction velocity as well as comparison of sensory conduc-
tion velocity in the carpal tunnel with that in the forearmBMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/9
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Table 1: Results of the nerve conduction tests (right hands) in the persons with carpal tunnel syndrome (CTS) and the controls
Nerve conduction test, mean (95% 
confidence interval)
Clinically certain CTS (n = 86) Symptomatic Controls (n = 155) Asymptomatic Controls (n = 124)*
Median nerve distal motor latency 
(ms)
4.2 (4.0–4.4)† 3.6 (3.5–3.7) 3.4 (3.3–3.5)
Median nerve digit 3-wrist sensory 
latency (ms)‡
3.6 (3.4–3.8)† 3.0 (2.9–3.1) 2.9 (2.8–3.0)
Median nerve wrist-palm sensory con-
duction velocity (m/s)‡
39.2 (36.5–41.9)† 48.3 (46.8–49.8) 50.7 (49.4–52.0)
Ulnar nerve distal motor latency (ms) 2.7 (2.6–2.7) 2.7 (2.6–2.7) 2.8 (2.7–2.8)
Ulnar nerve digit 5-wrist sensory 
latency (ms)
2.3 (2.2–2.3) 2.3 (2.3–2.4) 2.3 (2.3–2.4)
Median-ulnar nerve sensory latency 
difference (ms)
1.3 (1.1–1.5)† 0.72 (0.65–0.79) 0.57 (0.52–0.62)
* One of the 125 controls did not undergo testing on the right hand because of previous laceration. † Significantly worse than in the controls (p < 
0.001). ‡ Absent sensory responses in 3 persons with CTS (for both tests in 2 persons) and in one symptomatic control (both tests); in calculating 
means, absent latency values were replaced with the most abnormal value recorded.
Table 2: Receiver operating characteristic (ROC) analysis comparing the diagnostic accuracy of the nerve conduction tests performed 
on 153 symptomatic hands of persons with clinically certain carpal tunnel syndrome and 247 asymptomatic control hands*
Nerve conduction test Area under ROC curve† 95% confidence interval for difference 
(between 2 successive tests)
Median nerve distal motor latency 0.75
-0.02–0.03
Median nerve digit 3-wrist sensory latency 0.76
-0.04–0.02
Median nerve wrist-palm sensory conduction 
velocity
0.76
-0.07 – -0.01
Median-ulnar nerve sensory latency difference 0.80‡
0.01–0.08
Median nerve wrist-palm/forearm sensory con-
duction velocity ratio
0.76
* Two of the 125 asymptomatic control persons declined nerve conduction testing on the left hand and one did not undergo testing on the right 
hand because of previous laceration. † 1 indicates perfect accuracy and 0.5 indicates accuracy no better than chance. ‡ Significantly different from the 
other four tests (two-tailed p = 0.004 for all comparisons).
Table 3: Diagnostic test properties of digit-wrist median-ulnar sensory latency difference (0.8 ms cutoff value for abnormal result) in 
population-based carpal tunnel syndrome (CTS) with the clinical diagnosis as criterion standard
Test property* Symptomatic persons with clini-
cally certain CTS
Asymptomatic control persons Asymptomatic and symptomatic 
control persons
Sensitivity 70.2 (61.0–79.5) (n 66/94)
Specificity 81.6 (74.8–88.4) 73.7 (68.7–78.8)
(n 102/125)( n 216/293)
Positive predictive value (PPV) 18.7 (15.0–22.3) 16.2 (13.0–19.4)
(n 83/445)( n 83/551)
Negative predictive value (NPV) 97.9 (97.2–98.6) 98.0 (97.4–98.7)
(n 1608/1643)( n 1755/1790)
*shown as % (95% confidence interval), number of persons from which the rate was derived shown in italic; Sensitivity = true positives/(true posi-
tives + false negatives); Specificity = true negatives/(true negatives + false positives); PPV = true positives/(true positives + false positives); NPV = 
true negatives/(true negatives + false negatives); PPV and NPV were calculated based on the assumption that the same rates of disease or test 
abnormality found among the samples examined applied to the corresponding groups among all survey responders as described in the text and pre-
viously [8].BMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/9
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had similar diagnostic power while median-ulnar sensory
latency difference demonstrated higher accuracy.
No consensus exists regarding the type and number of
nerve conduction tests needed to establish the neurophys-
iological diagnosis in CTS. Moreover, there is no consen-
sus on the definition of abnormality [13]. In addition to
median nerve motor and wrist-digit sensory latency meas-
urements, numerous new tests have been successively in-
troduced to improve the sensitivity of nerve conduction
tests [1]. Performing multiple nerve conduction tests on
an individual would increase the likelihood of obtaining
a false positive result [14]. Measurements of wrist-palm
sensory conduction or median-ulnar comparison have
been considered superior to distal motor and digit-wrist
sensory latency measurements, particularly in detecting
patients with mild CTS [15].
The strengths of the present study lie in its population-
based design, the independent clinical and electrophysio-
logical assessments, and the use of ROC curves comparing
the overall performance of different diagnostic tests rather
than their performance at specific cutoff values. A possible
limitation of this study, also shared by almost all previous
studies, is the use of the clinical diagnosis of CTS as the
criterion standard against which electrodiagnostic tests
were assessed. However, no superior criterion standard for
the assessment of nerve conduction tests is currently avail-
able, and the analysis involved comparison of different
tests in the same population. The diagnosis of CTS, which
determined the sensitivity of the nerve conduction tests,
was made by the examining surgeon before testing and
was supported independently by a validated hand dia-
gram. Estimation of specificity was based on the results of
nerve conduction tests performed on completely asymp-
tomatic persons randomly selected from a general popu-
lation. The examining surgeon verified the absence of
symptoms in the hands confirming the control persons'
responses to the questionnaire.
A discrepancy exists between the results of this study and
those of many previous reports regarding the sensitivity
and specificity of nerve conduction tests and, in particular,
the similar performance of median nerve motor and sen-
sory conduction tests. Although most previous clinical
studies have shown sensory conduction tests to be more
sensitive than motor conduction tests, this finding has not
been consistent [2]. The discrepancy shown might have
been caused by several factors such as methodological dif-
ferences, with the majority of previous studies being based
on (1) referred patients with CTS and/or small conven-
ience samples of controls (in those that did include con-
trols) as opposed to random population-based samples,
(2) non-blinded as opposed to blinded neurophysiologi-
cal examinations and interpretations, and (3) compari-
sons of sensitivity of different tests in patients using
certain cutoff values as opposed to comparison of their
overall performance in persons with CTS and controls.
The cutoff value would determine the sensitivity of a cer-
tain test; for distal motor latency the cutoff values used in
different studies have ranged from 3.8 ms to 4.6 ms [4].
The requirement, stated in the practice parameter, that
each neurophysiological laboratory should have its own
"reference values" [5] does not facilitate a standardized as-
sessment of diagnostic tests. Difference in the
demographic characteristics and disease severity among
the patient populations studied is yet another factor that
could explain the differences in the reported sensitivity for
nerve conduction tests in CTS. Although the present
study, like other studies that have shown moderate sensi-
tivity for nerve conduction tests, may face the frequently
stated argument that the "most sensitive" tests were not
used, this argument ignores the limitations of these diag-
nostic tests [13].
The performance of nerve conduction tests in this popula-
tion-based investigation does not necessarily apply to
their performance in the diagnosis of CTS in clinical set-
tings. The sensitivity estimates in the present study may
apply to populations that are similar to the sample exam-
ined, being representative of a general population with a
wide spectrum of disease severity. The results of the tests
in this population showed few persons with absent senso-
ry responses (Table 1), more commonly seen in patients
with severe CTS.
Although it is recognized that patients with typical CTS
might have normal nerve conduction test results, the exact
size of this group has not been specifically investigated. In
a recent consensus report on CTS, the authors stated that
consensus could not be reached regarding the patients
with typical symptoms but normal nerve conduction test
results [16]. In two prospective clinical studies that used
the clinical diagnosis of CTS as well as complete symptom
relief after surgery as the criterion standard, the sensitivity
of nerve conduction testing was 78% and 74%, respective-
ly [17,18]. The statement made in the practice parameter
that the sensitivity of nerve conduction tests exceeds 85%
at a specificity of 95% [5] appears to lack strong support-
ive evidence; this can only be determined with a high de-
gree of certainty by performing appropriately designed
randomized clinical studies and testing large population
random samples of asymptomatic persons [13].
The present study showed a relatively high level of false
positive test results (18%) for nerve conduction tests us-
ing a cutoff value considered optimal according to the
ROC analysis. The most common method of estimating
specificity has been to perform nerve conduction tests on
a group of "normal" persons who in almost all previousBMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/9
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studies have been recruited among hospital employees or
similar convenience samples. The normal values have
then been calculated based on the mean values plus 2 to
3 standard deviations recorded in these control groups.
Owing to the nature of this method, high specificity is ob-
tained and values of 95% to 97% are usually reported [5].
However, when a test the specificity of which had been
calculated with this method in a control group is then
used in a different population of "normal" persons, the
specificity obtained might be markedly worse.
False positive nerve conduction test results in CTS have
been reported previously. In a population-based study
from England, a mail survey of 1000 persons (age, 18 to
75 years) found that symptoms of numbness, tingling, or
pain in at least 2 of the 3 radial fingers were reported by
18% of the 648 responders [19]. Electrophysiological ex-
amination of about half of the symptomatic persons and
of 40 randomly selected asymptomatic persons showed
median neuropathy (defined as distal motor latency
above 4.5 ms or wrist-digit sensory latency above 3.7 ms)
in only 18% of those with symptoms of CTS and in 20%
of the asymptomatic persons [19]. In a study of 50 asymp-
tomatic persons (mean age, 34 years) the specificity of
median-ulnar wrist-palm latency difference of 0.5 ms was
reported to be 100% [14]; the use of the same test and cut-
off value in a subsequent study of 1021 job applicants
gave false positive test results in 16% [20]. In another
study of 824 workers (mean age, 38 years) the same test
and cutoff value also showed abnormal test results in 16%
of the asymptomatic workers (cutoff value of 0.8 ms also
gave false positive test results) [21]. Surprisingly, in the re-
cent extensive literature review [4], on which the updated
practice parameter was based, the above-cited studies that
have shown a high rate of abnormal nerve conduction test
results among completely asymptomatic persons were not
included.
In the present study, a cutoff value derived from the stand-
ard deviations calculated for the control sample would
have yielded a markedly worse sensitivity. In the absence
of a universally accepted criterion standard for the diagno-
sis of CTS and as in other non-perfect diagnostic tests, a
cutoff value should be chosen that yields sensitivity and
specificity levels that can be considered acceptable for
clinical purposes. The results of the ROC analyses showed
that, with acceptable levels of specificity, the sensitivity of
nerve conduction tests would not be very high. These find-
ings, similar to a previous report [22] support the view
that the diagnosis of CTS ought to be clinical, with nerve
conduction tests used to provide objective evidence when
necessary, and to support the diagnosis in less typical cas-
es. The findings are, however, based on a clinical diagno-
sis made by an experienced hand surgeon. Because, in
clinical practice, physicians with varying experience man-
age patients with CTS, the diagnostic role of nerve conduc-
tion tests becomes more important.
Relying solely on the clinical examination in making the
diagnosis of CTS might lead not only to missing the diag-
nosis of CTS in some patients but also to incorrect diagno-
sis and unnecessary surgery in others. On the other hand,
relying solely on nerve conduction tests might lead to
some patients who actually have CTS being denied surgi-
cal treatment because of their normal test results. Despite
the limitations of nerve conduction testing, it is the only
tool currently available that can provide direct evidence of
median neuropathy at the carpal tunnel to strongly sup-
port the diagnosis of CTS in symptomatic patients. Nerve
conduction testing also provides an assessment of the se-
verity of median neuropathy, which can be helpful in
making decisions concerning type of treatment. Further-
more, in clinical research assessing treatment efficacy in
CTS, nerve conduction testing can be useful as part of the
inclusion criteria to improve the overall diagnostic cer-
tainty; this can minimize the risk of misclassification that
reduces the study's ability to detect true differences. How-
ever, the results of such studies may not be generalized to
patients who are diagnosed on clinical grounds only,
which is probably more common in clinical practice.
Predictive values of diagnostic tests are dependent upon
disease prevalence. The low positive predictive value for
nerve conduction testing is not unusual in a disease with
a prevalence rate of less than 5% [8] in the general popu-
lation. This suggests that nerve conduction tests are not
suitable for screening purposes among non-patient popu-
lations. The positive predictive value would be much
higher when the tests are used on patients presenting with
symptoms of numbness and tingling in the hands.
Besides possessing higher diagnostic accuracy than that of
isolated median nerve motor and sensory conduction
tests, measurement of median-ulnar latency difference has
the advantage of being less influenced by factors such as
age, height, weight, and hand temperature. It has been
suggested that ulnar nerve involvement might be present
in CTS as shown by symptoms and sensory loss involving
the ulnar fingers and the resolution of these findings after
carpal tunnel release [23,24]. The similarity of ulnar nerve
motor and sensory latencies among the persons with clin-
ically certain CTS and the controls shown in the present
study suggests that ulnar nerve conduction abnormalities
in association with CTS are uncommon.
The standardized hand symptom diagram [6,7] demon-
strated high sensitivity but poor specificity in the diagno-
sis of CTS among this population-based sample of
persons with numbness and tingling in the hand. Conse-
quently, if the diagram is used among populations for thePublish with BioMed Central    and   every 
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purpose of screening for CTS, the final diagnosis ought to
be confirmed through a detailed history taken by a
physician.
In conclusion, nerve conduction testing has moderate
sensitivity and specificity and a low positive predictive val-
ue in population-based CTS. Among the various motor
and sensory nerve conduction tests, measurement of me-
dian-ulnar sensory latency difference appears to have the
highest diagnostic accuracy.
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